RXMD is not a typical OTC stock and thus has atypical people investing in it. Wonder why people like Jimmy were not on here all weekend? Well, besides the fact they probably had better things to do, its likely because they weren't concerned about whether we had a pop today. These people are investors looking 2-3 years out and not whether they can make a quick buck today. In other words, its atypical because most interest here is by investors not traders.
Further, much of the float is locked up by these long-term investors. Traders have come to realize that selling their shares for a short-term gain, will likely result in difficulty replacing those shares at a low price, particularly if they had a large amount of shares. Put simply, longs are not cooperating with the traders by furnishing them with a fresh supply of cheap shares. A few hundred thousand shares can move the price up very quickly.
I spend a lot of time checking out other companies here in OTC land. Most of them are shady at best and out right scams at the worst. This company has real property, real customers, and real revenues. That might not seem like a high bar but how many other OTC companies could get a conventional million dollar mortgage for a building? My guess would be very few.
Now I don't purport to have the answer as to when the stock price will begin reflecting this company's value but when they begin reporting consolidated revenues and quarterly reports, it will be hard for people to ignore the doubling of revenue.
Wolf
AI
Market Data 
Markets 
